Actively Recruiting
Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
Led by Malin Olsen Syversen · Updated on 2024-05-16
240
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
Sponsors
M
Malin Olsen Syversen
Lead Sponsor
O
Oslo University College
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating how to improve medication management for patients with multiple long-term conditions, which poses challenges due to complex medication treatments and the risk of medication discrepancies during transitions between healthcare levels. The study aims to understand medication discrepancies and gather perceptions from patients, their families, and healthcare personnel to develop a new, seamless, person-centered intervention. It uses both quantitative and qualitative methods within a design thinking framework to better support patients' self-efficacy and improve communication about medications across care levels. The study includes three parts: a quantitative medication reconciliation study involving 150 to 200 patients to identify types and frequencies of medication discrepancies after hospital discharge; qualitative semi-structured interviews with 20 to 30 patients and next of kin to explore experiences with medication use and shared decision-making; and interviews with 15 to 20 healthcare professionals involved in medication management. Workshops involving patients, families, healthcare workers, researchers, and designers will develop prototypes for the new intervention based on insights gathered. Participants will be recruited from specific hospital wards and provide informed consent. Data collection includes medication reconciliation, interviews, field notes, and demographic information. The study assesses medication discrepancies, patient and family perceptions, and healthcare professionals' views to identify barriers and facilitators for improved medication care. The primary outcome is the frequency and type of medication discrepancies within two years after discharge. Safety and confidentiality are maintained, with no invasive procedures, and participants may withdraw at any time. The study started in 2022 and is expected to continue until 2027.
CONDITIONS
Brief Title
Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult aged 18 years or older
- Provides written, informed consent (or consent from next of kin if not competent)
- Resident of Oslo
- Lives at home and manages medications themselves, possibly with help from home-care nurses or next of kin
- Scheduled for discharge from hospital wards to home or short-term nursing home stay
- Uses at least four regular medications from at least two therapy classes
- Healthcare personnel or next of kin involved in patient's medication management after discharge
- Healthcare personnel should be general practitioners or home-care nurses
- Able and willing to give written, informed consent
You will not qualify if you...
- Patients who are terminally ill or isolated due to infections
- Previously included in the study
- Have advanced cognitive failure as assessed by a physician
- Not being discharged to home (e.g., transfer to another ward or long-term nursing home stay)
- Unable to communicate in Norwegian or English
- Healthcare personnel or next of kin previously included in the study
- Healthcare personnel or next of kin unable to communicate in Norwegian or English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) close to hospital discharge (1-3 days ahead)
Duration - Up to 2 years
Participants take part in medication reconciliation and semi-structured interviews to explore medication use, discrepancies, and perceptions from patients, next of kin, and healthcare professionals after hospital discharge.
1 to 2 visits approximately 1-2 weeks after hospital discharge, with additional follow-up interviews for selected patients 3 to 4 weeks later
Duration - Ongoing during study period until July 2024
Selected participants engage in workshops with stakeholders to develop and prototype intervention models based on insights from the inspiration phase.
Workshops involving groups of 6 to 8 participants; exact visit frequency varies
Trial Site Locations
Total: 1 location
1
Oslo University Hospital
Oslo, Norway, 0484
Actively Recruiting
Research Team
M
Malin O Syversen, Msc
L
Liv Mathiesen, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here